Expert Corner

ImmuPharma Share Price Prediction (2025–2030): Expert Analysis & Predictions

Jun 7, 2025 | By Team SR

ImmuPharma Share Price Prediction (2025–2030): Expert Analysis & Predictions

As investors look to capitalize on emerging biotech opportunities, ImmuPharma has gained attention for its pioneering peptide-based therapies. With its listing on the London Stock Exchange and a steady focus on innovative biopharmaceutical development, many are searching for the ImmuPharma share price forecast for both the near and long term.

In this comprehensive analysis, we break down the ImmuPharma share price prediction from 2025 to 2030. Whether you're looking for the ImmuPharma share price forecast today UK, planning for tomorrow, or thinking long-term, this post provides expert-driven insights supported by current data.


About ImmuPharma

ImmuPharma PLC is a biopharmaceutical company focused on the research and development of peptide-based therapeutics. Peptides are naturally occurring molecules that occupy a unique space between small molecule drugs and large proteins, making them promising candidates for treating a wide range of conditions. The company's flagship drug, Lupuzor, targets autoimmune diseases like lupus and has been a focal point of its R&D efforts.


ImmuPharma Share Price Overview (Today)

As of the latest data:

  • Current Price: 2.675 GBX
  • Previous Close: 2.675 GBX
  • Change: 0.00 (0.00%)
  • Volume: 0
  • Open / High / Low / Bid / Ask: All static at 0.00 GBX

While the trading is flat today, the long-term potential lies in clinical trial success, FDA/EMA approvals, and licensing deals.


ImmuPharma Share Price Forecast 2025

MonthForecast Price (GBX)
January2.78
February2.84
March2.90
April3.01
May3.08
June3.15
July3.21
August3.32
September3.40
October3.52
November3.60
December3.75

ImmuPharma Share Price Forecast 2026

MonthForecast Price (GBX)
January3.80
February3.90
March4.02
April4.15
May4.25
June4.38
July4.52
August4.60
September4.74
October4.85
November4.96
December5.10

ImmuPharma Share Price Forecast 2027

MonthForecast Price (GBX)
January5.20
February5.35
March5.45
April5.58
May5.72
June5.88
July6.01
August6.15
September6.28
October6.40
November6.56
December6.70

ImmuPharma Share Price Forecast 2028

MonthForecast Price (GBX)
January6.85
February7.00
March7.18
April7.32
May7.45
June7.60
July7.74
August7.88
September8.00
October8.12
November8.28
December8.40

ImmuPharma Share Price Forecast 2029

MonthForecast Price (GBX)
January8.55
February8.70
March8.85
April9.00
May9.18
June9.30
July9.45
August9.60
September9.75
October9.90
November10.05
December10.20

ImmuPharma Share Price Forecast 2030

MonthForecast Price (GBX)
January10.35
February10.52
March10.68
April10.85
May11.02
June11.18
July11.35
August11.50
September11.66
October11.80
November11.95
December12.10

Conclusion - ImmuPharma Share Price

The ImmuPharma share price forecast UK shows promising signs of growth through 2030. From a modest rise in 2025 to a potential quadrupling by 2030, much depends on regulatory outcomes and clinical milestones. The ImmuPharma share price forecast today UK may not yet reflect its long-term trajectory, but investors seeking biotech exposure could see strong returns.

Stay updated on the ImmuPharma share price forecast tomorrow and watch for developments in pipeline drugs that could impact valuation.


FAQs: ImmuPharma Share Price Forecast

What is the ImmuPharma share price forecast for 2025?

The forecast ranges from 2.78 GBX in January to 3.75 GBX by December 2025.

Is ImmuPharma a good long-term investment?

Based on pipeline potential and projected growth, ImmuPharma may be a solid long-term speculative play in the biotech sector.

What is the ImmuPharma share price forecast UK for tomorrow?

With trading activity currently static, tomorrow’s forecast suggests minimal short-term movement unless driven by news or updates.

How does ImmuPharma’s peptide focus influence its share price?

Peptides are a novel drug class with significant therapeutic promise, which can positively impact investor sentiment and valuation as trials succeed.

Explore more:-

AFC Energy Share Price PredictionXtract Share Price Prediction
Petrofac Share Price PredictionPremier African Minerals Share Price Prediction
Hemogenyx Share Price PredictionGenedrive Share Price Prediction
THG Share Price PredictionNovacyt Share Price Prediction
Eurasia Mining Share Price PredictionKodal Minerals Share Price Prediction
Shell Share Price PredictionBP plc Share Price Prediction
National Grid Share Price PredictionTesco Share Price Prediction
Legal & General Share Price PredictionTaylor Wimpey Share Price Prediction
Jet2 Share Price PredictionGlencore Share Price Prediction
Sainsbury’s Share Price PredictionAstraZeneca Share Price Prediction
British American Tobacco Share Price PredictionGlaxoSmithKline (GSK) Share Price Prediction
Centrica Share Price PredictionRio Tinto Share Price Prediction
Harbour Energy Share Price PredictionBoohoo Group Share Price Prediction
EasyJet plc Share Price PredictionPhoenix Group Share Price Prediction
Aviva Share Price PredictionVodafone Share Price Prediction

Disclaimer:

  • The information is based on our understanding of the stock's historical performance.
  • Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
  • The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
  • For further inquiries about the stock market, please contact us via email.

Recommended Stories for You